Your browser doesn't support javascript.
loading
Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.
Beneforti, Linda; Chinnici, Aurora; Coniglio, Maria Luisa; Papa, Maria Rosaria; Punzi, Liana; Sieni, Elena; De Fusco, Carmela.
Affiliation
  • Beneforti L; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Chinnici A; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Coniglio ML; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
  • Papa MR; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Punzi L; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Sieni E; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy.
  • De Fusco C; Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy.
Br J Haematol ; 205(3): 1234-1237, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38986479
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Italy Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Italy Country of publication: United kingdom